Disease Progression: Various factors that influence HBV disease progression including genotype, viral load (HBV DNA), hepatitis B e antigen (HBeAg) status, steatosis, obesity, insulin resistance, and general studies on disease progression.




        923. High Prevalence of HBV-DNA in Children with Chronic Hepatitis B after Seroconversion to Anti-Hbe


Development of Cirrhosis and Liver Cancer

        820. Fusion HBx from HBV integrant in human hepatoma cell line is implicated in the development and progression of hepatocellular carcinoma

        841. Pattern of serial HBV DNA level and HCC development in Patients with Liver Cirrhosis

        845. Clinical Significance of Low Viral Load in Antiviral Treatment-naive HBsAg Positive Patients (Updated Nov 2)

        847. Future Hepatitis Activation and Hepatocarcinogenesis in HBeAg-Negative HBV Carriers with Persistently Normal Alanine Aminotransferase, a Prospective Cohort Study

        848. Rituximab Leads to Reactivation of Hepatitis B in Individuals with Resolved Infection

        867. Accumulation of Hepatitis B Virus DNA in Hepatocellular Carcinoma of Patients with Sustained Virological Response for Hepatitis C Virus

        982. Oncologist Compliance with Recommendations for Hepatitis B Serostatus Testing: Experience from an academic hospital.



        317. Role of Viral and Clinical Factors Predicting the Outcomes of Patients with Hepatitis B Virus-Related Acute Liver Failure


Role of Genotypes and Mutations

        818. Reactive Oxygen Species Induce Liver Fibrosis in uPA/SCID Mice with Human Hepatocytes Infected with Specific Hepatitis B Virus Genotypes

        851. Influences of Hepatitis B Virus Genotype and Precore Mutations on Reactivation of Occult Hepatitis B in Patients with Hematological Malignancy

        863. Drifting of HBV-specific CTL Epitope HBcAg18-27V to HBcAg18-27I in Most HBV Genotype B and C Virus Strains in China

        864. Large Deletion Mutants of Hepatitis B Virus with Amino Acid Substitutions in the Core Region Emerges and Dominates Around the Onset of Active Hepatitis in Persistent HBV Carriers

        868. Increasing Frequency of Acute Hepatitis B with Imported Strain Genotype A in Japan

        869. Non-A Hepatitis B Genotypes are Associated with More Liver Fibrosis in HIV/HBV Patients

        870. Higher Levels of HBV-DNA in Genotypes B and C Compared to Genotypes A and D

        871. The Frequency of T126 in Surface Antigen Increase with Disease Progression in Patients with Chronic Hepatitis B Virus (Genotype C) Infection

        872. Mechanism for the Dependence of Hepatitis B Virus Genotypes G on Coinfection with Other Genotypes for Viral Replication

        989. Precore (PC) and Basic Core Promoter (BCP) Mutations and Genotypes in Relation to Viral Replication in Asymptomatic HBsAg-Positive Blood Donors in Greece


Role of HBeAg Status

        815. Age-specific Prognosis Following HBeAg Seroconversion in Chronic Hepatitis B

        829. Evolution of HBV Quasipecies Generates New CpG Dinucleotides Prior to HBeAg Seroconversion

        838. Histological Findings Of HBeAg-negative Chronic HBV -Infected Patients With Persistently Normal Serum Alanine Aminotransferase Levels

        861. Hepatitis B Viral Factors Influencing the Histological Changes Of HBeAg-negative Chronic HBV Infected Patients With Persistently Normal Serum Alanine Aminotransferase Levels

        862. Hepatitis B Virus Basal Core Promoter Mutation and DNA Load Correlate with Expression of Hepatitis B Core Antigen


Viral Replication and Integration

        816. Cleavage of Duck Hepatitis B Virus Envelope Protein by Endosomal Proprotein Convertase Promotes Viral cccDNA Formation in Non-susceptible LMH Cells

        817. HBx Protein Is Necessary for HBV Replication in Human Hepatocytes

        819. Mechanism of Hepatitis B Virus Persistence Following an Acute Infection A study using duck hepatitis B virus of the roles of virus replication and cell turnover.

        822. Cytopathic Effect of Hepatitis B Virus Obtained from Fulminant Hepatitis Patients

        825. Increased Innate and Adaptive Immune Pressure Is Responsible for the Reduced Transcriptional Activity of Intrahepatic Covalently-Closed Circular (ccc) DNA That Occurs in HBeAg-negative Chronic Hepatitis B (CHB)

        828. Cellular Immune Response to Recombinant Surface and Core HBV Antigens Is Not Impaired in Blood Donors with Occult Hepatitis B Infection

        831. High Prevalence of Hepatic Steatosis and its Impact on Fibrosis in Chronic Hepatitis B

        832. RIG-I signaling Expression in Monocyte-derived Dendritic Cells in Patients with Hepatitis B virus infection

        833. Hepatitis B virus-replication could induce sHSP60 and enhance regulatory T cell activity via toll like receptor 2

        834. T-1993C Polymorphism in The Promoter of TBX21 Gene Is Associated With Susceptibility to Persistent Hepatitis B Virus Infection

        835. A previously unidentified subset of CD4-CD8-T cells contributes to the persistence of chronic viral hepatitis via virus specific killing of CD8+ T cells

        837. Intrahepatic Analysis of Cytokine and Toll-like Receptor Signaling Expression in Chronic Hepatitis B Patients with Different HBV Replicative Activity

        843. Genetic Variability on the cccDNA Regulatory Regions Changes Significantly in the Different Phases of Chronic HBV Infection

        844. Single nucleotide polymorphisms and functional analysis of Class II transactivator (CIITA) coding region in chronic HBV infection

        849. Control of HBV Replication by HepaRG cells Innate Response

        854. Plasmacytoid Dendritic Cell Function Is Impaired in Chronic Hepatitis B Infection

        856. Viral Hepatitis B Virus (HBV) Promotes Extracellular Matrix Disruption Promoted by Viral Transactovatpr X (HBx) and Mediated by Gelatinase A.

        857. Modulation of Human Hepatic Stellate Cells (HSCS) Behavior by Hepatitis B Virus (HBV) X Protein (HBX) Through Transforming Growth Factor Beta Signalling Pathway

        858. High HBV DNA Load, HBeAg Positivity and Considerable Hepatic Necro Inflammation in Patients with Incidentally Detected, Asymptomatic Chronic HBV-infected Individuals from Bangladesh

        859. Lack of Correlation Between Viral Load and Extent of Liver Damage in Patients with Chronic HBV Infection in Bangladesh

        860. Modulation of ERK, AKT, apoptosis and cell cycle in primary mouse hepatocytes and Huh7 cells by wild-type and rtM204I HBV.

        855. Assessment of Delta and Hepatitis B Viremia in Patients with Chronic Hepatitis Delta. Influence of HIV Infection and Antiviral Therapy.